Bob Langer and Yann LeCun join Cellular Intelligence advisory board

Cellular Intelligence, an AI drug discovery company, said Moderna co-founder Bob Langer and Meta Chief AI Scientist Yann LeCun have joined its advisory board. The company focuses on using AI to advance cell biology research, with the stated goal of reshaping regenerative medicine. According to Cellular Intelligence, the two appointments are expected to speed up the use of AI in drug development, especially in work tied to understanding and intervening at the cellular level. The company also said it is building an AI-based platform designed to improve the efficiency of discovering and designing new therapies. The update was cited by Crypto Briefing and carried by Techub News.